Selected Start-Ups (4/03)
Executive SummaryIn Vivo briefly summarizes the technologies of these recently founded companies: AdvanDx Inc., AngioDesign Inc., Chiasma Inc., Ocularis Pharma Inc., Trism Inc. and Zelos Therapeutics Inc.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.